New Results
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19
Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, Kyle R. Kays, Mayra Pinilla-Vera, Maura E. Benson, MGH COVID-19 Collection & Processing Team, Lisa A. Cosimi, Deborah T. Hung, Bruce D. Levy, Alexandra-Chloe Villani, Moshe Sade-Feldman, Rebecca M. Baron, Marcia B. Goldberg, View ORCID ProfilePaul C. Blainey, Nir Hacohen
doi: https://doi.org/10.1101/2020.09.02.280180
Miguel Reyes
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
2Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
Michael R. Filbin
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Roby P. Bhattacharyya
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Abraham Sonny
5Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Arnav Mehta
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
6Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Kianna Billman
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
Kyle R. Kays
3Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Mayra Pinilla-Vera
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Maura E. Benson
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Lisa A. Cosimi
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Deborah T. Hung
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Bruce D. Levy
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Alexandra-Chloe Villani
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
8Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Moshe Sade-Feldman
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
6Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Rebecca M. Baron
7Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Marcia B. Goldberg
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Paul C. Blainey
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
2Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
Nir Hacohen
1Broad Institute of MIT and Harvard, Cambridge, MA, USA
6Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Posted September 02, 2020.
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19
Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, Kyle R. Kays, Mayra Pinilla-Vera, Maura E. Benson, MGH COVID-19 Collection & Processing Team, Lisa A. Cosimi, Deborah T. Hung, Bruce D. Levy, Alexandra-Chloe Villani, Moshe Sade-Feldman, Rebecca M. Baron, Marcia B. Goldberg, Paul C. Blainey, Nir Hacohen
bioRxiv 2020.09.02.280180; doi: https://doi.org/10.1101/2020.09.02.280180
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19
Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, Kyle R. Kays, Mayra Pinilla-Vera, Maura E. Benson, MGH COVID-19 Collection & Processing Team, Lisa A. Cosimi, Deborah T. Hung, Bruce D. Levy, Alexandra-Chloe Villani, Moshe Sade-Feldman, Rebecca M. Baron, Marcia B. Goldberg, Paul C. Blainey, Nir Hacohen
bioRxiv 2020.09.02.280180; doi: https://doi.org/10.1101/2020.09.02.280180
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)